resiquimod has been researched along with Breast Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Casettari, L; Figueiredo, P; Fontana, F; Hirvonen, J; Kostiainen, MA; Lepland, A; Santos, HA; Scodeller, P; Shahbazi, MA; Teesalu, T; Tiboni, M; Torrieri, G | 1 |
Allen, R; Ferrara, KW; Fite, BZ; Ilovitsh, A; Ingham, ES; Kakwere, H; Kheirolomoom, A; Lewis, JS; Liu, C; Nura-Raie, M; Tam, SM; Tumbale, SK; Wu, B; Zhang, H | 1 |
Bahmani, B; Bui, JD; DeTeresa, E; Fang, RH; Gao, W; Gong, H; Haushalter, KJ; Luk, BT; Previti, M; Zhang, J; Zhang, L; Zhou, J | 1 |
Liu, Y; Qin, J; Wan, G; Wang, Y; Yang, X; Zhang, M; Zhang, N; Zhou, C; Zhou, P | 1 |
4 other study(ies) available for resiquimod and Breast Neoplasms
Article | Year |
---|---|
Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
Topics: Breast Neoplasms; Female; Humans; Imidazoles; Lignin; Nanoparticles; Peptides; Phenotype; Tissue Distribution; Tumor Microenvironment; Tumor-Associated Macrophages | 2021 |
Systemic Immunotherapy with Micellar Resiquimod-Polymer Conjugates Triggers a Robust Antitumor Response in a Breast Cancer Model.
Topics: Animals; Breast Neoplasms; CD8-Positive T-Lymphocytes; Humans; Imidazoles; Immunity; Immunotherapy; Mice; Micelles; Nanoparticles; Polymers | 2021 |
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors.
Topics: Animals; Blood Platelets; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cells, Cultured; Female; HT29 Cells; Humans; Imidazoles; Immunotherapy; Lung Neoplasms; Mice, Inbred C57BL; Nanoparticles; Neoplasms; Treatment Outcome; Tumor Microenvironment | 2021 |
Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer.
Topics: Animals; Breast Neoplasms; Copper; Female; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Immunotherapy; Mice; Nanoparticles; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2019 |